English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/164253
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Título

DNA-based Nanoscaffolds as Vehicles for 5-fluoro-2’-deoxyuridine Oligomers in Colorectal Cancer Therapy

AutorJorge, A. F.; Aviñó, Anna; Pais, A. A. C. C.; Eritja Casadellà, Ramón; Fàbrega, C.
Palabras claveDNA nanostructures
Fluoropyrimidines
Colorectal cancer
5-fluorouracil
Fecha de publicación10-abr-2018
EditorRoyal Society of Chemistry (Great Britain)
CitaciónNanoscale 10: 7238-7249 (2018)
ResumenFluoropyrimidines, such as 5-fluorouracil (5-FU) and related prodrugs, are considered one of the most successful agents in the treatment of colorectal cancer, yet poor specificity and tumor cell resistance remain the major limiting bottlenecks. Here, we exploited for the first time the ability of two DNA nanoscaffolds, a DNA tetrahedron (Td) and rectangle DNA origami, to incorporate 5-fluoro-2′-deoxyuridine (FdUn) oligomers. In addition, cholesterol moieties were synthetically attached to Td and DNA origami staples to enhance cellular uptake. DNA nanostructures functionalized with FdUn exhibited an enhanced cytotoxicity and higher ability to trigger apoptosis in colorectal cancer cells relative to conventional 5-FU and FdU, especially having cholesterol as an internalization helper. The cholesterol content mostly correlates with the increase of the FdUn nanostructure cytotoxicity. DNA nanoscaffolds bearing FdUn were able to circumvent the low sensitivity of colorectal cancer cells towards 5-FU. Both DNA nanostructures attained a comparable cytotoxic effect yet Td displays higher antiproliferative action. The ability to reduce the proliferation of cancer cells is mainly related to the concentration of DNA nanostructures. The present work suggests that self-assembled DNA nanoparticles are privileged vehicles for delivering fluoropyrimidines, opening new avenues to the development of promising therapeutics for cancer treatment.
Versión del editor10.1039/C7NR08442K
URIhttp://hdl.handle.net/10261/164253
DOI10.1039/C7NR08442K
Aparece en las colecciones: (IQAC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
DNA-based Nanoscaffolds as Vehicles for 5-fluoro-2’-deoxyuridine.pdf Embargado hasta 10 de abril de 20192,17 MBAdobe PDFVista previa
Visualizar/Abrir     Petición de una copia
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.